Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for October 31, 2014

October 31, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Globus, up on Q3 beat, surprises with CFO resignation

October 31, 2014 by Brad Perriello

Globus Medical shares gain on its better-than-forecast 3rd quarter as the orthopedics company announces the surprise resignation of CFO Richard Baron.

Globus, up on Q3 beat, surprises with CFO resignation

Temporary tax hit pushes NuVasive into Q3 red

October 31, 2014 by Brad Perriello

NuVasive swings to a 3rd-quarter loss on higher-than-expected taxes, but beats Wall Street's sales expectations and says it expects to recoup the loss next quarter.

Temporary tax hit pushes NuVasive into Q3 red

Microsoft launches $199 wearable fitness device

October 31, 2014 by MassDevice

Microsoft launches its 'Microsoft Band' wearable device for just under $200, saying the device is designed to track pulse rate, calories burned and sleep quality.

Microsoft launches $199 wearable fitness device

Insurer owes Stryker $8m for Duracon Uni-Knee settlements

October 31, 2014 by Brad Perriello

A federal judge rules that TIG Insurance Co. owes Stryker Corp. nearly $8 million to cover deals the orthopedics company made to settle product liability lawsuits concerning its Duracon Uni-Knee implants.

Insurer owes Stryker $8m for Duracon Uni-Knee settlements

Zimmer reveals post-Biomet merger plans

October 31, 2014 by Brad Perriello

Zimmer reveals the management team and business structure it plans to put in place once its $13 billion merger with rival Biomet closes.

Zimmer reveals post-Biomet merger plans

U.S. sales narrow HeartWare's Q3 losses

October 31, 2014 by Val Kennedy

HeartWare posts narrowed 3rd-quarter losses thanks to increased sales of its implantable heart pumps in the U.S.

U.S. sales narrow HeartWare's Q3 losses

HeartWare International (NSDQ:HTWR) yesterday reported narrowed 3rd-quarter losses and significantly higher revenues, boosted by a 39% jump in U.S. sales of its implantable heart pumps.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp